Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Video of ASE President Stephen Little, MD, discussing trends in interventional echo at the ASE 2023 annual meeting.

Interventional echocardiography expected to grow thanks to new structural heart procedures

American Society of Echocardiography (ASE) President Stephen Little, MD, says there will be an increasing need for interventional echocardiographers in the near future.

August 22, 2023
Video of Partho Sengupta, MD, explaining two major shifts in AI for echocardiography at ASE 2023. These include GPT and deep learning to automate measurements. #ASE23 #ASE2023 #ASE #AI

2 key reasons the use of AI in echocardiography is growing

Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.

August 16, 2023
HCM expert Sherif F. Nagueh, MD, FACC, FASE, professor of cardiology, Methodist DeBakey Heart and Vascular Center, explains the key points of HCM imaging. #ASE #HCM

How medical imaging helps cardiologists treat hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy expert Sherif F. Nagueh, MD, examined imaging's role in treating this serious condition. 

August 9, 2023
Hari Naidu, MD, explains that inconsistent diagnostic imaging and how it is reported has likely led to a major underdiagnosis of HCM. #ASE #ASE2023 #HCM

Why hypertrophic cardiomyopathy may be widely underdiagnosed

One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.

August 8, 2023
SCCT President Ed Nicol, MD, explains key trends trends in cardiac CT imaging at the 2023 meeting. #SCCT #SCCT23 #SCCT2023

Key trends and takeaways in cardiac CT at SCCT 2023

Several key trends at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography were outlined by society President Ed Nicol, MD, including AI, reimbursement issue, business management discussions, and a growing interest in cardiac CT leading to record attendance this year.

August 1, 2023
HeartFlow's RoadMap technology where AI reads the image in a first pass to highlight areas of interest with for the radiologist or cardiologist on coronary CT scan. The technology was shown to reduce reading time by 25%.

Three studies show value of AI to speed cardiac CT reads and soft plaque evaluation 

AI to help interpret cardiac CT was shown to reduce exam read times to improve workflow efficiency, and improve patient diagnostics with additional information on soft plaques. Data was presented in three HeartFlow AI technology studies at SCCT 2023.

July 31, 2023
Ultrasight's AI to guide echo cardiac ultrasound POCUS exams at ASE 2023. The thumbnail of the chest shows the user how to the position the transducer and where to move or stop for image acquisition. The bar graph shows the quality of the image.

FDA clears new AI to guide point-of-care cardiac ultrasound exams

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.

July 31, 2023
Video of Maddie Jankowski explaining sonographer highlights and trends at the American Society of Echo (ASE) 2023 meeting.

The rise of AI and other key takeaways for sonographers at ASE 2023

Cardiac sonographer Maddie Jankowski, BS, ACS, RDCS, joined us to explore key trends and updates for sonographers from ASE 2023 in National Harbor, Maryland. 

July 25, 2023

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Trimed Popup
Trimed Popup